tradingkey.logo
tradingkey.logo
Search

Cullinan Therapeutics Inc

CGEM
Add to Watchlist
16.500USD
-1.020-5.82%
Close 07-31 16:00ETQuotes delayed by 15 min
1.01BMarket Cap
LossP/E TTM

CGEM Financials

See Cullinan Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cullinan Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.82/-0.83
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-3.72
-19.62%
Analyst Rating
STRONG BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
0.25%-0.82
-5.37%-0.86
-23.22%-0.86
-55.49%-1.19
4.67%-0.82
-46.20%-0.81
24.17%-0.70
5.32%-0.76
39.38%-0.86
5.00%-0.56
---0.92
---0.81
---1.42
---0.59
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
Net Profit
-2.39%-49.66M
-6.43%-50.71M
-24.78%-50.61M
-66.69%-70.06M
-30.56%-48.50M
-100.17%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.91%-37.15M
11.12%-23.80M
-57.97%-39.18M
-118.42%-32.21M
-379.10%-57.96M
17.63%-26.78M
-42.96%-24.80M
1218.56%174.90M
-17182.86%-12.10M
-14.70%-32.51M
-76.00%-17.35M
---15.64M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.39%
--0.36%
--0.36%
--0.03%
----
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
Operating profit
2.36%-53.70M
-0.38%-55.26M
-13.80%-55.59M
-51.51%-75.80M
-27.93%-55.00M
-21.02%-55.05M
-9.04%-48.85M
-33.03%-50.03M
31.50%-42.99M
-39.49%-45.48M
-50.52%-44.80M
-6.21%-37.60M
-92.17%-62.76M
5.06%-32.61M
-61.99%-29.77M
-113.24%-35.41M
-1690.70%-32.66M
-17.74%-34.35M
-59.80%-18.38M
---16.60M
Net Profit
-2.39%-49.66M
-6.43%-50.71M
-24.78%-50.61M
-66.69%-70.06M
-30.56%-48.50M
-100.17%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.91%-37.15M
11.12%-23.80M
-57.97%-39.18M
-118.42%-32.21M
-379.10%-57.96M
17.63%-26.78M
-42.96%-24.80M
1218.56%174.90M
-17182.86%-12.10M
-14.70%-32.51M
-76.00%-17.35M
---15.64M
Current assets
13.73%361.41M
-6.73%386.76M
-42.19%342.24M
-59.29%275.91M
-28.71%317.77M
-13.65%414.67M
24.19%592.04M
36.04%677.80M
11.70%445.72M
1.21%480.19M
-18.10%476.71M
-20.01%498.24M
23.80%399.03M
59.99%474.47M
77.01%582.08M
80.81%622.84M
-27.94%322.31M
39.71%296.56M
238.90%328.84M
229.13%344.47M
Total current liabilities
28.54%35.15M
23.15%37.74M
35.34%32.76M
19.52%28.06M
24.74%27.35M
8.92%30.65M
3.24%24.20M
19.31%23.48M
-16.22%21.93M
25.06%28.14M
-13.55%23.44M
-68.28%19.68M
51.65%26.17M
91.54%22.50M
244.87%27.12M
980.18%62.03M
74.42%17.26M
-17.97%11.75M
1.69%7.86M
-3.74%5.74M
Total assets
-30.48%402.98M
-27.89%448.37M
-25.89%484.13M
-23.62%520.33M
28.98%579.68M
28.43%621.82M
32.05%653.25M
30.51%681.22M
-12.73%449.43M
-13.71%484.18M
-19.85%494.71M
-21.77%521.98M
17.72%514.99M
28.35%561.12M
36.13%617.24M
43.69%667.25M
-8.80%437.46M
103.62%437.19M
365.90%453.40M
342.41%464.35M
Total liabilities
32.22%36.81M
25.87%39.64M
29.01%32.76M
12.75%28.18M
17.16%27.84M
3.99%31.50M
-1.92%25.39M
11.54%25.00M
-19.00%23.77M
16.10%30.29M
-16.78%25.89M
-64.22%22.41M
63.07%29.34M
120.88%26.09M
292.30%31.11M
977.43%62.63M
80.53%17.99M
-17.94%11.81M
1.59%7.93M
-3.76%5.81M
Total equity
-33.65%366.17M
-30.76%408.73M
-28.11%451.37M
-25.00%492.15M
29.64%551.84M
30.06%590.33M
33.92%627.86M
31.36%656.22M
-12.35%425.67M
-15.16%453.89M
-20.01%468.82M
-17.37%499.57M
15.78%485.65M
25.78%535.03M
31.57%586.13M
31.86%604.62M
-10.69%419.47M
112.35%425.37M
397.68%445.47M
363.55%458.54M
Net operating income
-6.70%-46.05M
-4.05%-38.11M
-8.02%-36.88M
-58.74%-57.61M
-12.83%-43.16M
-102.01%-36.63M
0.01%-34.14M
-17.05%-36.29M
25.00%-38.25M
27.43%-18.13M
37.19%-34.14M
-21.97%-31.01M
-132.78%-51.00M
-64.68%-24.98M
-415.15%-54.35M
-56.95%-25.42M
-1346.07%-21.91M
-60.78%-15.17M
-16.32%-10.55M
---16.20M
Net investment
-11.93%32.41M
40.26%22.39M
239.03%67.39M
128.85%53.40M
184.08%36.80M
-68.98%15.96M
146.27%19.88M
-1628.59%-185.11M
-14.67%12.96M
279.90%51.47M
25.91%-42.96M
-95.97%12.11M
-56.26%15.18M
-80.37%-28.61M
-126.54%-57.98M
294.61%300.85M
125.20%34.71M
-238.65%-15.86M
-1218.55%-25.59M
---154.59M
Net financing
--380.00K
-54.80%715.00K
-100.00%0.00
-99.86%373.00K
-100.00%0.00
537.90%1.58M
1083.04%1.32M
579.23%262.20M
-39.35%1.08M
100.75%248.00K
-92.14%112.00K
1817.64%38.60M
-49.48%1.79M
-1318.06%-32.91M
146.11%1.43M
118.09%2.01M
-98.66%3.54M
-97.84%2.70M
-51.99%579.00K
--923.00K

FAQs

What are the current assets of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its current assets were 386.76M, with a year-on-year change of -6.73.

What are the total assets of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its total assets of Cullinan Therapeutics Inc were 448.37M, with a year-on-year change of -27.89.

What are the total liabilities of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its total liabilities of Cullinan Therapeutics Inc were 39.64M, with a year-on-year change of 25.87.

What is the total equity of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its total equity of Cullinan Therapeutics Inc was 408.73M, with a year-on-year change of -30.76.

What is the net operating income of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its net operating income of Cullinan Therapeutics Inc was -241.65M, with a year-on-year change of -22.71.

What is the net investment of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its net investment of Cullinan Therapeutics Inc was 179.99M, with a year-on-year change of 232.04.

What is the net financing of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its net financing of Cullinan Therapeutics Inc was 1.09M, with a year-on-year change of -99.59.

What is the Earnings Per Share (EPS) of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.72, with a year-on-year change of -19.62.

What is the net income of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its net income was -219.88M, with a year-on-year change of -31.36.

What is the Return on Equity (ROE) of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -44.02, with a year-on-year change of -37.28.

What is the Return on Assets (ROA) of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -41.09, with a year-on-year change of -35.60.

What is the operating profit of Cullinan Therapeutics Inc?

According to Cullinan Therapeutics Inc's FY2025 earnings report, its operating profit was -241.65M, with a year-on-year change of -22.71.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.